Entangled Capital SGR
Entangled Capital SGR is a Milan-based independent private equity manager founded in 2019 that runs the EC I fund, taking control and co-control stakes in lower-mid-market Italian family-owned SMEs (revenues typically below about 50 million euros) across industrial, machinery, packaging and food niches, backing organic growth and buy-and-build. Its founding team previously managed four funds dedicated to Italian SMEs. EC I raised over 100 million euros and booked its first exit with the 2025 sale of pharma-glass platform Alphial to SGD Pharma.
Key facts
Recent exits
Coverage notes
1 fund tracked, 7 portfolio companies (6 active · 1 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
7 companiesFunds & portfolio
Every fund Entangled Capital SGR has raised, with its portfolio companies. Hand-checked from public filings.
EC ISmall-Mid BuyoutHarvesting2019 · 7yr€102M6 active · 1 realized
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Industrials | 2022 | ||
| Industrials | 2023 | ||
| Industrials | 2021 | ||
| Consumer | 2024 | ||
| Deep Tech | 2024 | ||
| Industrials | 2022 |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on Entangled Capital SGR.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in